Navigation Links
Azotobacter vinelandii

Multiporator / Electroporator 2510 Transformation Protocol

Protocol No. 4308 915.503 04/2002

Microorganism Azotobacter vinelandii Cell type Bacteria, gram negative Molecules injected Plasmid DNA Growth medium Nitrogen-free medium Washing solution Ice-cold 10% sterile glycerol Electroporation solution Ice-cold 10% sterile glycerol Outgrowth medium Azotobacter growth (AG) medium Cuvette 1 mm gap width Reference Kornyi, P. et al 1998 Research in Microbiology 149 361-372

Making electrocompetent cells:

  1. Cultivate cells with vigorous shaking at 30 C to an O.D.620 of 0.4-0.5.

  2. Harvest by centrifugation at 5,000 rpm for 10 min at 0 C.

  3. Wash with the original culture volume of ice-cold 10% glycerol.

  4. Repeat this step three times using a half and a quarter of the original volume, and finally 2-4 ml of the glycerol solution (7.0 x 107 cells/ml final cell concentration).

  5. Freeze 40 l aliquots in liquid nitrogen and store at 70 C.

Electroporation of cells:

  1. Add 1 l (300 ng/l) plasmid DNA to 40 l of electrocompetent cells. Homogenize by gently mixing with pipette

  2. several times. Transfer mixture into a prechilled cuvette.
  3. Wipe moisture from the cuvette and insert the cuvette into the device.

  4. Electroporation:

  5. Mode Prokaryotes O Voltage (V) 1,800 V Time constant (T)
    5 ms No. of pulses (n) 1
  6. Immediately add 1 ml AG medium and incubate with shaking at 200 rpm for 1 h at 30 C.

  7. Plate onto selective AG media plates.

Expected results:

Transformation efficiency up to 6.8 x 105 transformants/g of DNA.


'"/>

Source:


Page: All 1 2

Related biology technology :

1. Azotobacter vinelandii
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/10/2019)... ... January 08, 2019 , ... ... (SAGICO), an innovative spinal implant company, announced today that SAGICO will be ... California. The annual J.P. Morgan Healthcare Conference is the largest and ...
(Date:1/8/2019)... ... January 07, 2019 , ... Today ... Noninvasix. This represents the second investment AngelMD has made into Noninvasix in the ... is developing a patient monitor to directly, accurately, and noninvasively measure brain oxygenation ...
(Date:1/7/2019)... ... January 07, 2019 , ... ... of its Parkinson's Disease drug candidate, code-named "KM-819." KM-819 is an orally ... trial took place in South Korea. , This Phase 1 randomized, double-blind, ...
(Date:1/4/2019)... ... January 01, 2019 , ... uBiome, the ... World Economic Forum Annual Meeting January 22-25, 2019 held in Davos-Klosters, Switzerland following ... World Economic Forum Annual Meeting brings together leaders of global society–the heads and ...
Breaking Biology Technology:
(Date:1/4/2019)... ... January 02, 2019 , ... ... noteworthy, as the life science tools and service supplier turned 40 in 2018 ... catalog. The catalog features not just part numbers like most catalogs, but rather, ...
(Date:12/27/2018)... ... , ... AxioMed completed its initial production of ... is now raising growth capital to ramp up demand for orders already placed, ... and socket discs. The capital raise is targeted to qualified private investors with ...
(Date:12/22/2018)... ... , ... On Wednesday, Dec. 12, Greenberg Traurig, LLP’s ... Chen, Greater China Managing Partner of L.E.K. Chen shared her insights on “Biopharma ... David J. Dykeman , co-chair of Greenberg Traurig’s global Life Sciences ...
Breaking Biology News(10 mins):